1beta,2alpha-Dimethyl-3beta,4alpha-bis(2,4,5-trimethoxyphenyl)cyclobutane

Details

Top
Internal ID 64f5c168-e130-4af1-8e36-5061f849b4e3
Taxonomy Lignans, neolignans and related compounds > Cyclobutane lignans
IUPAC Name 1-[(1R,2S,3S,4R)-2,3-dimethyl-4-(2,4,5-trimethoxyphenyl)cyclobutyl]-2,4,5-trimethoxybenzene
SMILES (Canonical) CC1C(C(C1C2=CC(=C(C=C2OC)OC)OC)C3=CC(=C(C=C3OC)OC)OC)C
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@@H]1C2=CC(=C(C=C2OC)OC)OC)C3=CC(=C(C=C3OC)OC)OC)C
InChI InChI=1S/C24H32O6/c1-13-14(2)24(16-10-20(28-6)22(30-8)12-18(16)26-4)23(13)15-9-19(27-5)21(29-7)11-17(15)25-3/h9-14,23-24H,1-8H3/t13-,14-,23-,24-/m0/s1
InChI Key WCERJEZPIONOJU-NHCASCSRSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C24H32O6
Molecular Weight 416.50 g/mol
Exact Mass 416.21988874 g/mol
Topological Polar Surface Area (TPSA) 55.40 Ų
XlogP 4.90
Atomic LogP (AlogP) 4.89
H-Bond Acceptor 6
H-Bond Donor 0
Rotatable Bonds 8

Synonyms

Top
SCHEMBL5281908
1beta,2alpha-Dimethyl-3beta,4alpha-bis(2,4,5-trimethoxyphenyl)cyclobutane

2D Structure

Top
2D Structure of 1beta,2alpha-Dimethyl-3beta,4alpha-bis(2,4,5-trimethoxyphenyl)cyclobutane

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9936 99.36%
Caco-2 + 0.8852 88.52%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability + 0.8143 81.43%
Subcellular localzation Mitochondria 0.8537 85.37%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8925 89.25%
OATP1B3 inhibitior + 0.9642 96.42%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior + 0.9097 90.97%
P-glycoprotein inhibitior + 0.8440 84.40%
P-glycoprotein substrate - 0.8265 82.65%
CYP3A4 substrate - 0.6333 63.33%
CYP2C9 substrate - 0.5665 56.65%
CYP2D6 substrate + 0.3822 38.22%
CYP3A4 inhibition - 0.5052 50.52%
CYP2C9 inhibition - 0.9071 90.71%
CYP2C19 inhibition + 0.6949 69.49%
CYP2D6 inhibition - 0.9493 94.93%
CYP1A2 inhibition + 0.7771 77.71%
CYP2C8 inhibition - 0.8606 86.06%
CYP inhibitory promiscuity + 0.8126 81.26%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7350 73.50%
Carcinogenicity (trinary) Non-required 0.4436 44.36%
Eye corrosion - 0.9644 96.44%
Eye irritation - 0.8236 82.36%
Skin irritation - 0.8289 82.89%
Skin corrosion - 0.9677 96.77%
Ames mutagenesis - 0.5700 57.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8138 81.38%
Micronuclear - 0.5467 54.67%
Hepatotoxicity + 0.6159 61.59%
skin sensitisation - 0.8914 89.14%
Respiratory toxicity - 0.8667 86.67%
Reproductive toxicity + 0.5889 58.89%
Mitochondrial toxicity - 0.8625 86.25%
Nephrotoxicity + 0.5000 50.00%
Acute Oral Toxicity (c) III 0.6056 60.56%
Estrogen receptor binding + 0.8462 84.62%
Androgen receptor binding + 0.5632 56.32%
Thyroid receptor binding + 0.8129 81.29%
Glucocorticoid receptor binding + 0.6897 68.97%
Aromatase binding + 0.5313 53.13%
PPAR gamma + 0.6327 63.27%
Honey bee toxicity - 0.8356 83.56%
Biodegradation - 0.9000 90.00%
Crustacea aquatic toxicity + 0.8100 81.00%
Fish aquatic toxicity + 0.9715 97.15%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.30% 96.09%
CHEMBL241 Q14432 Phosphodiesterase 3A 90.43% 92.94%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.71% 86.33%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 83.28% 91.11%
CHEMBL4247 Q9UM73 ALK tyrosine kinase receptor 83.19% 96.86%
CHEMBL225 P28335 Serotonin 2c (5-HT2c) receptor 83.03% 89.62%

Cross-Links

Top
PubChem 10341859
NPASS NPC202904
ChEMBL CHEMBL345432
LOTUS LTS0032112
wikiData Q105301387